152 related articles for article (PubMed ID: 32767957)
21. Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms.
Dadashpour S; Emami S
Eur J Med Chem; 2018 Apr; 150():9-29. PubMed ID: 29505935
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activities of novel 1,2,4-triazolo[3,4-a]phthalazine derivatives.
Xue DQ; Zhang XY; Wang CJ; Ma LY; Zhu N; He P; Shao KP; Chen PJ; Gu YF; Zhang XS; Wang CF; Ji CH; Zhang QR; Liu HM
Eur J Med Chem; 2014 Oct; 85():235-44. PubMed ID: 25086915
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition.
Elmeligie S; Aboul-Magd AM; Lasheen DS; Ibrahim TM; Abdelghany TM; Khojah SM; Abouzid KAM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1347-1367. PubMed ID: 31322015
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
Zhang S; Zhao Y; Liu Y; Chen D; Lan W; Zhao Q; Dong C; Xia L; Gong P
Eur J Med Chem; 2010 Aug; 45(8):3504-10. PubMed ID: 20537434
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the synthesis of phthalazin-1(2H)-one core as a relevant pharmacophore in medicinal chemistry.
Terán C; Besada P; Vila N; Costas-Lago MC
Eur J Med Chem; 2019 Jan; 161():468-478. PubMed ID: 30388463
[TBL] [Abstract][Full Text] [Related]
26. Advances in 2-substituted benzothiazole scaffold-based chemotherapeutic agents.
Haider K; Rehman S; Pathak A; Najmi AK; Yar MS
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100246. PubMed ID: 34467567
[TBL] [Abstract][Full Text] [Related]
27. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.
Abou-Seri SM; Eldehna WM; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 Jan; 107():165-79. PubMed ID: 26590508
[TBL] [Abstract][Full Text] [Related]
28. Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives.
Eldehna WM; Abou-Seri SM; El Kerdawy AM; Ayyad RR; Hamdy AM; Ghabbour HA; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 May; 113():50-62. PubMed ID: 26922228
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of new phthalazine-based derivatives as potential EGFR inhibitors for the treatment of hepatocellular carcinoma.
Boraei ATA; Ashour HK; El Tamany ESH; Abdelmoaty N; El-Falouji AI; Gomaa MS
Bioorg Chem; 2019 Apr; 85():293-307. PubMed ID: 30654221
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of 2,4-disubstituted phthalazinones as Aurora kinase inhibitors.
Wang W; Feng X; Liu HX; Chen SW; Hui L
Bioorg Med Chem; 2018 Jul; 26(12):3217-3226. PubMed ID: 29705376
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in-vitro antitumor activity of 1-[3-(indol-1-yl)prop-1-yn-1-yl]phthalazines and related compounds.
Haider N; Kabicher T; Käferböck J; Plenk A
Molecules; 2007 Aug; 12(8):1900-9. PubMed ID: 17960095
[TBL] [Abstract][Full Text] [Related]
32. Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity.
Amin KM; Barsoum FF; Awadallah FM; Mohamed NE
Eur J Med Chem; 2016 Nov; 123():191-201. PubMed ID: 27484508
[TBL] [Abstract][Full Text] [Related]
33. Benzo[f]azino[2,1-a]phthalazinium cations: novel DNA intercalating chromophores with antiproliferative activity.
Martínez V; Burgos C; Alvarez-Builla J; Fernández G; Domingo A; García-Nieto R; Gago F; Manzanares I; Cuevas C; Vaquero JJ
J Med Chem; 2004 Feb; 47(5):1136-48. PubMed ID: 14971893
[TBL] [Abstract][Full Text] [Related]
34. Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymerase.
Loh VM; Cockcroft XL; Dillon KJ; Dixon L; Drzewiecki J; Eversley PJ; Gomez S; Hoare J; Kerrigan F; Matthews IT; Menear KA; Martin NM; Newton RF; Paul J; Smith GC; Vile J; Whittle AJ
Bioorg Med Chem Lett; 2005 May; 15(9):2235-8. PubMed ID: 15837300
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel phthalazinone derivatives as topically active phosphodiesterase 4 inhibitors.
Kagayama K; Morimoto T; Nagata S; Katoh F; Zhang X; Inoue N; Hashino A; Kageyama K; Shikaura J; Niwa T
Bioorg Med Chem; 2009 Oct; 17(19):6959-70. PubMed ID: 19744860
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and cytotoxic evaluation of some new phthalazinylpiperazine derivatives.
Liu Y; Zhang S; Li Y; Wang J; Song Y; Gong P
Arch Pharm (Weinheim); 2012 Apr; 345(4):287-93. PubMed ID: 22006840
[TBL] [Abstract][Full Text] [Related]
37. Novel antiasthmatic agents with dual activities of thromboxane A2 synthetase inhibition and bronchodilation. 1. 2-[2-(1-Imidazolyl)alkyl]-1(2H)-phthalazinones.
Yamaguchi M; Kamei K; Koga T; Akima M; Kuroki T; Ohi N
J Med Chem; 1993 Dec; 36(25):4052-60. PubMed ID: 8258827
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Investigation of Phthalazinones as Antitubercular Agents.
Santoso KT; Cheung CY; Hards K; Cook GM; Stocker BL; Timmer MSM
Chem Asian J; 2019 Apr; 14(8):1278-1285. PubMed ID: 30680937
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of novel benzylphthalazine derivatives as hedgehog signaling pathway inhibitors.
Bao X; Peng Y; Lu X; Yang J; Zhao W; Tan W; Dong X
Bioorg Med Chem Lett; 2016 Jul; 26(13):3048-3051. PubMed ID: 27180012
[TBL] [Abstract][Full Text] [Related]
40. Development of taladegib as a sonic hedgehog signaling pathway inhibitor.
Jin G; Sivaraman A; Lee K
Arch Pharm Res; 2017 Dec; 40(12):1390-1393. PubMed ID: 29159582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
